Rigshospitalet is the largest hospital in Denmark and the most highly specialised hospital in the country. The hospital's main building is a 16-storey functionalist highrise, one of the tallest structures in the central parts of the city.

There are 1,118 beds in Rigshospitalet; Hæmatologisk Klinik, Klinisk Afprøvnings Team KAT.

During the past decade, Rigshospitalet; Hæmatologisk Klinik, Klinisk Afprøvnings Team KAT conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rigshospitalet; Hæmatologisk Klinik, Klinisk Afprøvnings Team KAT" #1 collaborator was "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Rigshospitalet; Hæmatologisk Klinik, Klinisk Afprøvnings Team KAT" are "Lymphoma, Non-Hodgkin" (2 trials), "Multiple Myeloma" (2 trials), "Acute Myeloid Leukemia" (1 trials), "B-Cell Lymphoma" (1 trials) and "Non-Hodgkin Lymphoma" (1 trials). Many other conditions were trialed in "Rigshospitalet; Hæmatologisk Klinik, Klinisk Afprøvnings Team KAT" in a lesser frequency.

Most popular intervention types in "Rigshospitalet; Hæmatologisk Klinik, Klinisk Afprøvnings Team KAT" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Tocilizumab" (7 trials), "Glofitamab" (5 trials), "Obinutuzumab" (4 trials), "Dexamethasone" (2 trials) and "89Zr-Df-IAB22M2C" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rigshospitalet; Hæmatologisk Klinik, Klinisk Afprøvnings Team KAT" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Rigshospitalet; Hæmatologisk Klinik, Klinisk Afprøvnings Team KAT". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Rigshospitalet; Hæmatologisk Klinik, Klinisk Afprøvnings Team KAT, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rigshospitalet; Hæmatologisk Klinik, Klinisk Afprøvnings Team KAT, 8 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".